At Refocus, our Neuroscience arm is grounded in a single, evidence-based principle: the brain is capable of change. Through neuroplasticity, neural networks can strengthen, reorganise, or quieten in response to repeated patterns of attention, behaviour, and experience. This adaptive capacity underpins learning, recovery, and regulation across the lifespan.
A modern, non-invasive brain stimulation programme for depression, mental wellbeing, focus and resilience — designed for real life, not just crisis care.
At Refocus, our Neuroscience arm is grounded in a single, evidence-based principle: the brain is capable of change. Through neuroplasticity, neural networks can strengthen, reorganise, or quieten in response to repeated patterns of attention, behaviour, and experience. This adaptive capacity underpins learning, recovery, and regulation across the lifespan.
A modern, non-invasive brain stimulation programme for depression, mental wellbeing, focus and resilience — designed for real life, not just crisis care.
EXOMIND is a non-invasive transcranial magnetic stimulation (TMS) system that delivers magnetic pulses to stimulate nerve cells in specific brain regions.
Magnetic pulses precisely target key brain networks linked to mood regulation, cognitive function and self-control.
The aim is to support neuroplasticity—helping brain networks “reset” and communicate more effectively over time.
EXOMIND’s ExoTMS® technology is FDA-cleared for the treatment of depression in the context of its marketed indications.
Unlike traditional TMS pathways, we deliver a holistic, clinician-led programme tailored to your unique brain and life.
Not just crisis intervention
EXOMIND has been developed with a broader wellbeing and performance lens, aiming to support mood, motivation, cognitive clarity and resilience—especially relevant for busy, high-demand lives.
Not just crisis intervention
EXOMIND is designed to be comfortable and accessible, making it easier to complete a full course consistently—an important ingredient for meaningful change.
Not just crisis intervention
At Refocus, EXOMIND can be part of a wider plan that may include qEEG brain mapping, psychological strategies, medication review, and lifestyle-aware care.
EXOMIND may be suitable for adults looking for a non-invasive, medication-free (or medication-supportive) approach to improving brain network functioning.
Mood & Motivation
Perimenopause
Neurodivergent Adults
High Performers
Important: Suitability Depends On Clinical Screening And Safety Checks. We’ll Assess Your Individual Circumstances During Consultation.
Repetitive Transcranial Magnetic Stimulation (rTMS) has an expanding evidence base beyond clinical disorders, with growing research exploring its role in mental wellness, cognitive performance, and stress resilience.
Studies suggest that targeted prefrontal stimulation may support improvements in cognitive function, mental clarity, emotional regulation, and fatigue—symptoms commonly reported in burnout, brain fog, perimenopause, and high cognitive load states. TMS effects on neural networks involved in attention, executive function, and wellbeing.
Repetitive Transcranial Magnetic Stimulation (rTMS) has an established and robust evidence base in depression—particularly for individuals who have not responded adequately to antidepressant medication.
NICE guidelines support the use of rTMS for treatment-resistant depression when delivered using approved protocols and appropriate clinical governance, and rTMS is also FDA-approved for Major Depressive Disorder in adults.
Repetitive Transcranial Magnetic Stimulation (rTMS) has emerging evidence in binge eating and obsessive–compulsive disorder (OCD), particularly through its effects on impulse control, cognitive flexibility, and fronto-striatal circuits.
Clinical studies suggest that targeted prefrontal stimulation may reduce binge frequency, food cravings, and the intensity of intrusive or repetitive thoughts, with generally good tolerability.
Repetitive Transcranial Magnetic Stimulation (rTMS) has an emerging evidence base in Attention-Deficit/Hyperactivity Disorder (ADHD), particularly in relation to attention regulation, executive functioning, and emotional control.
Research studies suggest that targeted prefrontal stimulation may support improvements in attention, impulsivity, and cognitive control, especially in individuals who experience persistent symptoms despite standard interventions.
As a CQC-ready service, we maintain the highest standards of clinical governance and patient safety.
NICE has published guidance on rTMS for depression, noting no major safety concerns when used with appropriate governance.
EXOMIND’s ExoTMS has published early clinical outcomes in a peer-reviewed journal reporting improvements in mental wellbeing measures.
Validated scales and patient goals are tracked throughout treatment with referral pathways when needs are more complex.
Validated scales and patient goals are tracked throughout treatment with referral pathways when needs are more complex.
We assess your symptoms, history, medications, sleep, hormones, and neurodevelopmental profile to understand your unique situation.
Brain mapping to better understand your baseline brain patterns and guide a personalised treatment approach.
A comfortable, clinician-led programme delivered in our clinic with sessions designed around your schedule.
Regular reviews and plan refinement, including wider support where needed to ensure lasting improvement.
Exomind is a non-invasive brain stimulation treatment based on established transcranial magnetic stimulation (TMS) technology. It is generally well tolerated and does not involve medication or sedation.
For safety reasons, Exomind cannot be offered to individuals who:
● Have a history of epilepsy or seizures
● Are pregnant or breastfeeding
● Have metal implants near the head or implanted electronic devices (such as pacemakers)
● Have experienced psychotic episodes or have certain severe mental health conditions
● Are under 16 years of age
At Refocus, safety always comes first. Every Exomind programme is delivered within a medically governed framework, with access to consultant psychiatrists and neuroscience-informed care pathways.
IMPORTANT
Suitability depends on clinical screening and safety checks. We’ll assess your individual circumstances during consultation.
As a CQC-ready service, we maintain the highest standards of clinical governance and patient safety.
Exomind is a non-invasive brain stimulation treatment based on established transcranial magnetic stimulation
(TMS) technology. It is generally well tolerated and does not involve medication or sedation.
For safety reasons, Exomind cannot be offered to individuals who:
● Have a history of epilepsy or seizures
● Are pregnant or breastfeeding
● Have metal implants near the head or implanted electronic devices (such as pacemakers)
● Have experienced psychotic episodes or have certain severe mental health conditions
● Are under 16 years of age
At Refocus, safety always comes first. Every Exomind programme is delivered within a medically governed framework,
with access to consultant psychiatrists and neuroscience-informed care pathways.
